Previous studies by our team have uncovered the irreplaceable role of DCLK1-S in the development of esophageal squamous cell carcinoma by stimulating the MAPK/ERK/MMP2 pathway to promote the EMT process (Ge et al. 2021). Here, MMP2 is linked to esophageal squamous cell carcinoma.